Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKesson
Johnson and Johnson
Merck
Colorcon

Last Updated: August 15, 2022

Investigational Drug Information for Solithromycin


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Solithromycin?

Solithromycin is an investigational drug.

There have been 11 clinical trials for Solithromycin. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2013.

The most common disease conditions in clinical trials are Pneumonia, Bacterial, Pneumonia, and Gonorrhea. The leading clinical trial sponsors are Cempra Inc, Melinta Therapeutics, Inc., and Department of Health and Human Services.

There are one hundred and eleven US patents protecting this investigational drug and nine hundred and forty-seven international patents.

Recent Clinical Trials for Solithromycin
TitleSponsorPhase
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial PneumoniaBiomedical Advanced Research and Development AuthorityPhase 2/Phase 3
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial PneumoniaCempra IncPhase 2/Phase 3
Safety and Efficacy of Solithromycin in Adolescents and Children With Community-Acquired Bacterial PneumoniaMelinta Therapeutics, Inc.Phase 2/Phase 3

See all Solithromycin clinical trials

Clinical Trial Summary for Solithromycin

Top disease conditions for Solithromycin
Top clinical trial sponsors for Solithromycin

See all Solithromycin clinical trials

US Patents for Solithromycin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Solithromycin See Plans and Pricing Anti-CS1 antibodies and antibody drug conjugates AbbVie Biotherapeutics Inc. (Redwood City, CA) See Plans and Pricing
Solithromycin See Plans and Pricing Hamamelitannin analogues and uses thereof UNIVERSITEIT GENT (Ghent, BE) See Plans and Pricing
Solithromycin See Plans and Pricing Pharmaceutical composition for the treatment of multi-drug resistant infections Council of Scientific & Industrial Research (New Delhi, IN) See Plans and Pricing
Solithromycin See Plans and Pricing Treatments for resistant acne VYOME BIOSCIENNCES PVT. LTD. (New Delhi, IN) See Plans and Pricing
Solithromycin See Plans and Pricing Sulfur(VI) fluoride compounds and methods for the preparation thereof The Scripps Research Institute (La Jolla, CA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Solithromycin

Drugname Country Document Number Estimated Expiration Related US Patent
Solithromycin Australia AU2015339012 2034-10-31 See Plans and Pricing
Solithromycin Brazil BR112017008945 2034-10-31 See Plans and Pricing
Solithromycin Canada CA2966005 2034-10-31 See Plans and Pricing
Solithromycin European Patent Office EP3212668 2034-10-31 See Plans and Pricing
Solithromycin Spain ES2832711 2034-10-31 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
AstraZeneca
McKesson
Johnson and Johnson
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.